1,722,000 research outputs found
Clinical applicability of molecular biology: the case of the long QT syndrome
No full textAbstract The clinical applicability of molecular cardiology has been questioned at length and by many clinical investigators. The congenital long QT syndrome (LQTS) provides an excellent example of how tight the relationship can be between molecular biology and clinical cardiology. The advent of molecular diagnosis has demonstrated how low the penetrance can be in LQTS; this implies that there are many gene carriers who do not show the clinical phenotype and may have a normal QT interval despite being at risk. There is also a gene-specific predisposition to be at risk for cardiac arrest under different circumstances, and this provides additional basis for a gene-specific approach to therapy.</p
Cascades or Waterfalls, the Cataracts of Genetic Screening Are Being Opened on Clinical Cardiology**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
No full textNuovi rischi medico-legali per il cardiologo: la cardiologia molecolare ed il caso della sindrome del QT lungo.
No full text
[New ways to become embroiled in a medico-legal suit. Encounters of the third type between cardiologists and lawyers in the era of guidelines and of molecular biology].
No full text
Stillbirths, sudden infant deaths, and long QT syndrome. Puzzle or mosaic, the pieces of the jigsaw are being fitted together
Full text link
- …
